Ozempic maker Novo plans another US$4.1 billion US factory

Ozempic maker Novo plans another US.1 billion US factory

Novo Nordisk plans to invest US$4.1 billion in another US factory, ploughing more money into its biggest market amid rising discontent over the cost of its obesity and diabetes drugs. The project in Clayton, North Carolina, will double the company’s production footprint in the US, adding 1.4 million square feet of space for the final…

Read More

Olam Agri obtains US$550 million loan facility

Olam Agri obtains US0 million loan facility

OLAM Group’s indirect 64.6 per cent-owned subsidiary, Olam Agri, has secured a loan facility of US$550 million (S$743.7 million), said the group on Tuesday (Jun 25). The revolving credit facility, which has a tenor of three years, was obtained by Olam Agri’s subsidiaries, Olam Global Agri and Olam Global Agri Treasury. Proceeds from the…

Read More

Fearing losses, banks are quietly dumping real estate loans

Fearing losses, banks are quietly dumping real estate loans

SOME Wall Street banks, worried that landlords of vacant and struggling office buildings won’t be able to pay off their mortgages, have begun offloading their portfolios of commercial real estate loans hoping to cut their losses. It’s an early but telling sign of the broader distress brewing in the commercial real estate market, which is hurting…

Read More

Apple spurned idea of iPhone AI partnership with Meta months ago

Apple spurned idea of iPhone AI partnership with Meta months ago

APPLE rejected overtures by Meta Platforms to integrate the social networking company’s artificial intelligence (AI) chatbot into the iPhone months ago, according to sources with knowledge of the matter. The two companies are not in discussions about using Meta’s Llama chatbot in an AI partnership and only held brief talks in March, said the sources,…

Read More